Kapi'olani Women's Center — Honolulu, Hawaii

Kapi'olani Women's Center is a clinical research site located in Honolulu, Hawaii, United States 96826.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Kapi'olani Women's Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kapi'olani Women's Center?

Kapi'olani Women's Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kapi'olani Women's Center conducted?

Kapi'olani Women's Center has 1 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer.

Is Kapi'olani Women's Center accredited by Crixeo Health?

Kapi'olani Women's Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kapi'olani Women's Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.